Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.

ABSTRACT:

SUBMITTER: Landsburg DJ 

PROVIDER: S-EPMC11808862 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature